Merck is a Founding Corporate Partner
Cervical cancer is the most common cancer among sub-Saharan African women, according to the World Health Organization. Merck is working with government, non-profit and health organizations to help change that fact.
Merck has joined with Susan G. Komen for the Cure, the George W. Bush Institute, the President's Emergency Plan for AIDS Relief (PEPFAR), UNAIDS, the U.S. government and other corporate partners to launch Pink Ribbon-Red Ribbon, a historic initiative that aims to address the cervical and breast cancer crises in developing nations through disease education, screening and treatment efforts as well as increased access to cervical cancer vaccination.
The Pink Ribbon-Red Ribbon initiative was officially announced on Sept. 13 in Washington, D.C. at an event attended by Mr. and Mrs. George W. Bush, Secretary of State Hillary Rodham Clinton, Ambassador Nancy Brinker and representatives from UNAIDS, Susan G. Komen for the Cure and Merck. Merck was represented by Dr. Julie Gerberding, president of Merck Vaccines.
Utilizing the expertise of the founding partners, the Pink Ribbon-Red Ribbon initiative will focus on helping to raise awareness about cervical cancer and helping to deliver sustainable, regional resources specifically related to cervical and breast cancer. As a founding corporate partner, Merck is making a financial contribution of $3 million over three years and in kind contributions to a cervical cancer vaccination program in Tanzania as part of the Pink Ribbon-Red Ribbon initiative.